Pacific Bio (PACB) Reports In-Line Q4 EPS, Misses on Revenue

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Pacific Bio (PACB) Reports In-Line Q4 EPS, Misses on Revenue

PacBio Announces Fourth Quarter and Fiscal Year 2024 Financial Results

February 13, 2025 4:05 PM EST

MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024.

Fourth quarter results

Revenue of $39.2 million, a 33% decrease compared with $58.4 million in the prior-year period.Instrument revenue of $15.3 million compared with $35.1 million in the prior-year period. Instrument revenue in the fourth quarter of 2024 included 23 Revio® sequencing systems and 7 Vega sequencing systems.Consumables revenue of $18.8 million compared with $18.9 million in the prior-year... More